Managing Director of Bovogen Biologicals, Rick Clements teams up with Dr. David Kennedy from Biotechnology Development Ltd. to form and register a new company called Biovine Biologicals Pty Ltd.
Biovine Biologicals shall focus on the development and supply of ovine proteins and related products for the life science industries. Australia is one of a relative few countries that is scrapie free (ovine form of a transmissable spongiform encephalopathy) hence, making the country an excellent source of ovine biological products. Australia's abundant sheep herds also facilitates the sourcing of inexpensive raw materials.
Certain ovine blood clotting proteins shall also be developed and manufactured by Bovogen Biologicals on behalf of Biovine Biologicals for the development of haemostasis applications by international collaborators.
Biovine Biologicals' ovine based products shall also provide an alternative to traditional bovine sourced compounds hence, providing global life science industries with products that are not affected by BSE concerns.
For more information conatct Bovine Biologicals.